Cargando…

COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital

The novel, highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a pandemic of acute respiratory illness worldwide and remains a huge threat to the healthcare system’s capacity to respond to COVID-19. Elderly and immunocompromised patients are at increased r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wünsch, Korbinian, Anastasiou, Olympia E., Alt, Mira, Brochhagen, Leonie, Cherneha, Maxim, Thümmler, Laura, van Baal, Lukas, Madel, Rabea J., Lindemann, Monika, Taube, Christian, Witzke, Oliver, Rohn, Hana, Krawczyk, Adalbert, Jansen, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024512/ https://www.ncbi.nlm.nih.gov/pubmed/35458476 http://dx.doi.org/10.3390/v14040746

Ejemplares similares

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients
por: Thümmler, Laura, et al.
Publicado: (2022)

Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age
por: Konik, Margarethe, et al.
Publicado: (2021)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

Superior antiviral activity of IFNβ in genital HSV-1 infection
por: Schmitz, Yasmin, et al.
Publicado: (2022)

Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study
por: Alt, Mira, et al.
Publicado: (2023)

Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro
por: Bormann, Maren, et al.
Publicado: (2021)

SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma
por: Lindemann, Monika, et al.
Publicado: (2021)

Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA
por: Wolff, Natalie, et al.
Publicado: (2022)

Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients
por: Cherneha, Maxim, et al.
Publicado: (2021)

Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes
por: Bormann, Maren, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study
por: Korth, Johannes, et al.
Publicado: (2021)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
por: van de Sand, Lukas, et al.
Publicado: (2021)

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
por: Korth, Johannes, et al.
Publicado: (2020)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Susceptibility of SARS-CoV-2 to UV irradiation
por: Heilingloh, Christiane Silke, et al.
Publicado: (2020)

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
por: Schwarzkopf, Sina, et al.
Publicado: (2021)

Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2022)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses
por: van de Sand, Lukas, et al.
Publicado: (2021)

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients
por: van de Sand, Lukas, et al.
Publicado: (2022)

Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018)

COVID-19 in der Intensivmedizin
por: Floß, Niklas, et al.
Publicado: (2023)

Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant Recipients
por: Gäckler, Anja, et al.
Publicado: (2021)

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients
por: Mülling, Nils, et al.
Publicado: (2023)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
por: Möhlendick, Birte, et al.
Publicado: (2022)

Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

COVID-19 und die Niere
por: Rohn, H., et al.
Publicado: (2020)

COVID-19 und die Niere
por: Rohn, H., et al.
Publicado: (2020)

Akutes Nierenversagen bei COVID-19
por: Gäckler, A., et al.
Publicado: (2020)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

Evaluation of hemostasis in patients with end-stage renal disease
por: Gäckler, Anja, et al.
Publicado: (2019)

Increased resistance of gram-negative urinary pathogens after kidney transplantation
por: Korth, Johannes, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n7lev1qmfk4ig34nsg3q00t188